- Report
- January 2025
- 140 Pages
Global
From €3586EUR$3,950USD£3,089GBP
- Report
- August 2024
- 118 Pages
Middle East, Africa
From €3132EUR$3,450USD£2,698GBP
- Report
- November 2024
- 66 Pages
Global
From €1770EUR$1,950USD£1,525GBP
- Report
- June 2022
- 73 Pages
Global
From €1770EUR$1,950USD£1,525GBP
- Report
- March 2025
- 136 Pages
Global
From €4534EUR$4,995USD£3,906GBP
- Report
- August 2023
- 215 Pages
Global
€4353EUR$4,795USD£3,750GBP
- Report
- February 2026
- 150 Pages
Canada
From €4403EUR$4,850USD£3,793GBP
- Report
- February 2026
- 150 Pages
Germany
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2025
- 150 Pages
Global
From €4403EUR$4,850USD£3,793GBP
- Report
- March 2025
- 150 Pages
Global
From €4403EUR$4,850USD£3,793GBP
- Report
- December 2024
- 150 Pages
Global
From €4403EUR$4,850USD£3,793GBP
- Report
- September 2024
- 150 Pages
Global
From €4403EUR$4,850USD£3,793GBP
- Report
- December 2024
- 150 Pages
Global
From €3586EUR$3,950USD£3,089GBP
- Report
- November 2025
- 150 Pages
China
From €4403EUR$4,850USD£3,793GBP
- Report
- July 2025
- 150 Pages
United Kingdom
From €4403EUR$4,850USD£3,793GBP
- Report
- July 2025
- 150 Pages
Italy
From €4403EUR$4,850USD£3,793GBP
- Report
- April 2025
- 150 Pages
India
From €4403EUR$4,850USD£3,793GBP
- Report
- February 2026
- 80 Pages
United Kingdom
From €2587EUR$2,850USD£2,229GBP
- Report
- February 2026
- 83 Pages
China
From €2587EUR$2,850USD£2,229GBP
- Report
- February 2026
- 87 Pages
South Korea
From €2587EUR$2,850USD£2,229GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more